阿尔茨海默病临床谱系中脑MRI的脉络丛体积与通透性
该回顾性研究纳入532例有认知症状的患者,评估不同认知损害阶段脉络丛体积、通透性与磁化率。脉络丛体积随认知损害加重而增大(P < .001),且与记忆、执行功能和整体认知负相关(P = .01)。
要点
- 脉络丛体积随认知损害加重而增大,从主观认知损害到阿尔茨海默病逐级升高(P < .001)。
- 脉络丛体积与记忆、执行功能及整体认知呈负相关(B = -0.67、-0.90、-0.82)。
- Ktrans和Vp与脉络丛体积呈负相关(r = -0.19、-0.20),磁化率无显著关联(P = .10)。
核心结论
- 在有认知症状的患者中,较大的脉络丛体积与阿尔茨海默病谱系中认知损害严重程度相关。
研究设计与样本
- 回顾性研究,纳入532例有认知症状的患者(平均年龄72岁±9[SD],388例女性),于2013年1月至2020年5月行3.0-T脑MRI,包括动态对比增强(DCE)成像和定量磁化率映射(QSM);脉络丛体积用三维T1加权序列自动分割。
关键影像表现/征象
- 脉络丛体积与颅内体积比值×10³:主观认知损害0.9±0.3,早期轻度认知损害1.0±0.3,晚期轻度认知损害1.1±0.3,阿尔茨海默病1.3±0.4(P < .001)。
诊断标准与关键数值
- 脉络丛体积与颅内体积比值×10³:主观认知损害0.9±0.3,早期轻度认知损害1.0±0.3,晚期轻度认知损害1.1±0.3,阿尔茨海默病1.3±0.4(P < .001)。
- Ktrans与脉络丛体积负相关(r = -0.19;P = .03),Vp与脉络丛体积负相关(r = -0.20;P = .02),磁化率与脉络丛体积无显著关联(r = 0.15;P = .10)。
- 脉络丛体积与记忆负相关(B = -0.67;均值标准误[SEM] 0.21;P = .01),与执行功能负相关(B = -0.90;SEM 0.31;P = .01),与整体认知负相关(B = -0.82;SEM 0.32;P = .01)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Mounting evidence suggests that the choroid plexus (CP) plays an important role in the pathophysiology of Alzheimer disease (AD), but its imaging profile in cognitive impairment remains unclear. Purpose To evaluate CP volume, permeability, and susceptibility by using MRI in patients at various stages of cognitive impairment. Materials and Methods This retrospective study evaluated patients with cognitive symptoms who underwent 3.0-T MRI of the brain, including dynamic contrast-enhanced (DCE) imaging and quantitative susceptibility mapping (QSM), between January 2013 and May 2020. CP volume was automatically segmented using three-dimensional T1-weighted sequences; the volume transfer constant (ie, Ktrans) and fractional plasma volume (ie, Vp) were determined using DCE MRI, and susceptibility was assessed using QSM. The effects of CP volume, expressed as the ratio to intracranial volume, on cognition were evaluated using multivariable linear regression adjusted for age, sex, education, apolipoprotein E ε4 allele status, and volumetric measures. Results A total of 532 patients with cognitive symptoms (mean age, 72 years ± 9 [SD]; 388 women) were included: 78 with subjective cognitive impairment (SCI), 158 with early mild cognitive impairment (MCI), 149 with late MCI, and 147 with AD. Among these, 132 patients underwent DCE MRI and QSM. CP volume was greater in patients at more severe stages (ratio of intracranial volume × 103: 0.9 ± 0.3 for SCI, 1.0 ± 0.3 for early MCI, 1.1 ± 0.3 for late MCI, and 1.3 ± 0.4 for AD; P < .001). Lower Ktrans (r = -0.19; P = .03) and Vp (r = -0.20; P = .02) were negatively associated with CP volume; susceptibility was not (r = 0.15; P = .10). CP volume was negatively associated with memory (B = -0.67; standard error of the mean [SEM], 0.21; P = .01), executive function (B = -0.90; SEM, 0.31; P = .01), and global cognition (B = -0.82; SEM, 0.32; P = .01). Conclusion Among patients with cognitive symptoms, larger choroid plexus volume was associated with severity of cognitive impairment in the Alzheimer disease spectrum. Published under a CC BY 4.0 license. Online supplemental material is available for this article. See also the editorial by Chiang in this issue.
引用
- Choi, Moon, Kim, et al. Choroid Plexus Volume and Permeability at Brain MRI within the Alzheimer Disease Clinical Spectrum. Radiology. 2022. PMID: 35579521. doi:10.1148/radiol.212400
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。